1 Market Overview
1.1 Product Overview and Scope of Genetically Modified Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Genetically Modified Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Transgenic Animal
1.3.3 Transgenic Plant
1.4 Market Analysis by Application
1.4.1 Overview: Global Genetically Modified Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Genetically Modified Drug Market Size & Forecast
1.5.1 Global Genetically Modified Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Genetically Modified Drug Sales Quantity (2018-2029)
1.5.3 Global Genetically Modified Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 LFB Biotechnologies SA
2.1.1 LFB Biotechnologies SA Details
2.1.2 LFB Biotechnologies SA Major Business
2.1.3 LFB Biotechnologies SA Genetically Modified Drug Product and Services
2.1.4 LFB Biotechnologies SA Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 LFB Biotechnologies SA Recent Developments/Updates
2.2 Pharming Group NV
2.2.1 Pharming Group NV Details
2.2.2 Pharming Group NV Major Business
2.2.3 Pharming Group NV Genetically Modified Drug Product and Services
2.2.4 Pharming Group NV Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pharming Group NV Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Genetically Modified Drug Product and Services
2.3.4 Pfizer Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Genetically Modified Drug Product and Services
2.4.4 Roche Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Roche Recent Developments/Updates
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories Genetically Modified Drug Product and Services
2.5.4 Abbott Laboratories Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abbott Laboratories Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Genetically Modified Drug Product and Services
2.6.4 Johnson & Johnson Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Merck & Co.
2.7.1 Merck & Co. Details
2.7.2 Merck & Co. Major Business
2.7.3 Merck & Co. Genetically Modified Drug Product and Services
2.7.4 Merck & Co. Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck & Co. Recent Developments/Updates
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Genetically Modified Drug Product and Services
2.8.4 Amgen Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Amgen Recent Developments/Updates
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business
2.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product and Services
2.9.4 F. Hoffmann-La Roche Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 F. Hoffmann-La Roche Recent Developments/Updates
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Genetically Modified Drug Product and Services
2.10.4 Sanofi Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sanofi Recent Developments/Updates
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Genetically Modified Drug Product and Services
2.11.4 Novartis Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Novartis Recent Developments/Updates
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business
2.12.3 Eli Lilly Genetically Modified Drug Product and Services
2.12.4 Eli Lilly Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Eli Lilly Recent Developments/Updates
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Genetically Modified Drug Product and Services
2.13.4 Takeda Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Takeda Recent Developments/Updates
2.14 Baxter
2.14.1 Baxter Details
2.14.2 Baxter Major Business
2.14.3 Baxter Genetically Modified Drug Product and Services
2.14.4 Baxter Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Baxter Recent Developments/Updates
2.15 GlaxoSmithKline
2.15.1 GlaxoSmithKline Details
2.15.2 GlaxoSmithKline Major Business
2.15.3 GlaxoSmithKline Genetically Modified Drug Product and Services
2.15.4 GlaxoSmithKline Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 GlaxoSmithKline Recent Developments/Updates
3 Competitive Environment: Genetically Modified Drug by Manufacturer
3.1 Global Genetically Modified Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Genetically Modified Drug Revenue by Manufacturer (2018-2023)
3.3 Global Genetically Modified Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Genetically Modified Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Genetically Modified Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Genetically Modified Drug Manufacturer Market Share in 2022
3.5 Genetically Modified Drug Market: Overall Company Footprint Analysis
3.5.1 Genetically Modified Drug Market: Region Footprint
3.5.2 Genetically Modified Drug Market: Company Product Type Footprint
3.5.3 Genetically Modified Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Genetically Modified Drug Market Size by Region
4.1.1 Global Genetically Modified Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Genetically Modified Drug Consumption Value by Region (2018-2029)
4.1.3 Global Genetically Modified Drug Average Price by Region (2018-2029)
4.2 North America Genetically Modified Drug Consumption Value (2018-2029)
4.3 Europe Genetically Modified Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Genetically Modified Drug Consumption Value (2018-2029)
4.5 South America Genetically Modified Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Genetically Modified Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Genetically Modified Drug Sales Quantity by Type (2018-2029)
5.2 Global Genetically Modified Drug Consumption Value by Type (2018-2029)
5.3 Global Genetically Modified Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Genetically Modified Drug Sales Quantity by Application (2018-2029)
6.2 Global Genetically Modified Drug Consumption Value by Application (2018-2029)
6.3 Global Genetically Modified Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Genetically Modified Drug Sales Quantity by Type (2018-2029)
7.2 North America Genetically Modified Drug Sales Quantity by Application (2018-2029)
7.3 North America Genetically Modified Drug Market Size by Country
7.3.1 North America Genetically Modified Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Genetically Modified Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Genetically Modified Drug Sales Quantity by Type (2018-2029)
8.2 Europe Genetically Modified Drug Sales Quantity by Application (2018-2029)
8.3 Europe Genetically Modified Drug Market Size by Country
8.3.1 Europe Genetically Modified Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Genetically Modified Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Genetically Modified Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Genetically Modified Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Genetically Modified Drug Market Size by Region
9.3.1 Asia-Pacific Genetically Modified Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Genetically Modified Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Genetically Modified Drug Sales Quantity by Type (2018-2029)
10.2 South America Genetically Modified Drug Sales Quantity by Application (2018-2029)
10.3 South America Genetically Modified Drug Market Size by Country
10.3.1 South America Genetically Modified Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Genetically Modified Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Genetically Modified Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Genetically Modified Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Genetically Modified Drug Market Size by Country
11.3.1 Middle East & Africa Genetically Modified Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Genetically Modified Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Genetically Modified Drug Market Drivers
12.2 Genetically Modified Drug Market Restraints
12.3 Genetically Modified Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Genetically Modified Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Genetically Modified Drug
13.3 Genetically Modified Drug Production Process
13.4 Genetically Modified Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Genetically Modified Drug Typical Distributors
14.3 Genetically Modified Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Genetically Modified Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Genetically Modified Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. LFB Biotechnologies SA Basic Information, Manufacturing Base and Competitors
Table 4. LFB Biotechnologies SA Major Business
Table 5. LFB Biotechnologies SA Genetically Modified Drug Product and Services
Table 6. LFB Biotechnologies SA Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. LFB Biotechnologies SA Recent Developments/Updates
Table 8. Pharming Group NV Basic Information, Manufacturing Base and Competitors
Table 9. Pharming Group NV Major Business
Table 10. Pharming Group NV Genetically Modified Drug Product and Services
Table 11. Pharming Group NV Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pharming Group NV Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Genetically Modified Drug Product and Services
Table 16. Pfizer Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Roche Basic Information, Manufacturing Base and Competitors
Table 19. Roche Major Business
Table 20. Roche Genetically Modified Drug Product and Services
Table 21. Roche Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Roche Recent Developments/Updates
Table 23. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Laboratories Major Business
Table 25. Abbott Laboratories Genetically Modified Drug Product and Services
Table 26. Abbott Laboratories Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Abbott Laboratories Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Genetically Modified Drug Product and Services
Table 31. Johnson & Johnson Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 34. Merck & Co. Major Business
Table 35. Merck & Co. Genetically Modified Drug Product and Services
Table 36. Merck & Co. Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck & Co. Recent Developments/Updates
Table 38. Amgen Basic Information, Manufacturing Base and Competitors
Table 39. Amgen Major Business
Table 40. Amgen Genetically Modified Drug Product and Services
Table 41. Amgen Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Amgen Recent Developments/Updates
Table 43. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 44. F. Hoffmann-La Roche Major Business
Table 45. F. Hoffmann-La Roche Genetically Modified Drug Product and Services
Table 46. F. Hoffmann-La Roche Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. F. Hoffmann-La Roche Recent Developments/Updates
Table 48. Sanofi Basic Information, Manufacturing Base and Competitors
Table 49. Sanofi Major Business
Table 50. Sanofi Genetically Modified Drug Product and Services
Table 51. Sanofi Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sanofi Recent Developments/Updates
Table 53. Novartis Basic Information, Manufacturing Base and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Genetically Modified Drug Product and Services
Table 56. Novartis Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Novartis Recent Developments/Updates
Table 58. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 59. Eli Lilly Major Business
Table 60. Eli Lilly Genetically Modified Drug Product and Services
Table 61. Eli Lilly Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Eli Lilly Recent Developments/Updates
Table 63. Takeda Basic Information, Manufacturing Base and Competitors
Table 64. Takeda Major Business
Table 65. Takeda Genetically Modified Drug Product and Services
Table 66. Takeda Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Takeda Recent Developments/Updates
Table 68. Baxter Basic Information, Manufacturing Base and Competitors
Table 69. Baxter Major Business
Table 70. Baxter Genetically Modified Drug Product and Services
Table 71. Baxter Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Baxter Recent Developments/Updates
Table 73. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline Major Business
Table 75. GlaxoSmithKline Genetically Modified Drug Product and Services
Table 76. GlaxoSmithKline Genetically Modified Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GlaxoSmithKline Recent Developments/Updates
Table 78. Global Genetically Modified Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Genetically Modified Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Genetically Modified Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Genetically Modified Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Genetically Modified Drug Production Site of Key Manufacturer
Table 83. Genetically Modified Drug Market: Company Product Type Footprint
Table 84. Genetically Modified Drug Market: Company Product Application Footprint
Table 85. Genetically Modified Drug New Market Entrants and Barriers to Market Entry
Table 86. Genetically Modified Drug Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Genetically Modified Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Genetically Modified Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Genetically Modified Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Genetically Modified Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Genetically Modified Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Genetically Modified Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Genetically Modified Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Genetically Modified Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Genetically Modified Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Genetically Modified Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Genetically Modified Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Genetically Modified Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Genetically Modified Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Genetically Modified Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Genetically Modified Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Genetically Modified Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Genetically Modified Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Genetically Modified Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Genetically Modified Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Genetically Modified Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Genetically Modified Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Genetically Modified Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Genetically Modified Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Genetically Modified Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Genetically Modified Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Genetically Modified Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Genetically Modified Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Genetically Modified Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Genetically Modified Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Genetically Modified Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Genetically Modified Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Genetically Modified Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Genetically Modified Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Genetically Modified Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Genetically Modified Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Genetically Modified Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Genetically Modified Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Genetically Modified Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Genetically Modified Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Genetically Modified Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Genetically Modified Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Genetically Modified Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Genetically Modified Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Genetically Modified Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Genetically Modified Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Genetically Modified Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Genetically Modified Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Genetically Modified Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Genetically Modified Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Genetically Modified Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Genetically Modified Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Genetically Modified Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Genetically Modified Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Genetically Modified Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Genetically Modified Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Genetically Modified Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Genetically Modified Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Genetically Modified Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Genetically Modified Drug Raw Material
Table 146. Key Manufacturers of Genetically Modified Drug Raw Materials
Table 147. Genetically Modified Drug Typical Distributors
Table 148. Genetically Modified Drug Typical Customers
List of Figures
Figure 1. Genetically Modified Drug Picture
Figure 2. Global Genetically Modified Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Genetically Modified Drug Consumption Value Market Share by Type in 2022
Figure 4. Transgenic Animal Examples
Figure 5. Transgenic Plant Examples
Figure 6. Global Genetically Modified Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Genetically Modified Drug Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Genetically Modified Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Genetically Modified Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Genetically Modified Drug Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Genetically Modified Drug Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Genetically Modified Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Genetically Modified Drug Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Genetically Modified Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Genetically Modified Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Genetically Modified Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Genetically Modified Drug Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Genetically Modified Drug Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Genetically Modified Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Genetically Modified Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Genetically Modified Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Genetically Modified Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Genetically Modified Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Genetically Modified Drug Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Genetically Modified Drug Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Genetically Modified Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Genetically Modified Drug Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Genetically Modified Drug Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Genetically Modified Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Genetically Modified Drug Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Genetically Modified Drug Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Genetically Modified Drug Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Genetically Modified Drug Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Genetically Modified Drug Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Genetically Modified Drug Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Genetically Modified Drug Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Genetically Modified Drug Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Genetically Modified Drug Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Genetically Modified Drug Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Genetically Modified Drug Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Genetically Modified Drug Consumption Value Market Share by Region (2018-2029)
Figure 52. China Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Genetically Modified Drug Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Genetically Modified Drug Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Genetically Modified Drug Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Genetically Modified Drug Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Genetically Modified Drug Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Genetically Modified Drug Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Genetically Modified Drug Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Genetically Modified Drug Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Genetically Modified Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Genetically Modified Drug Market Drivers
Figure 73. Genetically Modified Drug Market Restraints
Figure 74. Genetically Modified Drug Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Genetically Modified Drug in 2022
Figure 77. Manufacturing Process Analysis of Genetically Modified Drug
Figure 78. Genetically Modified Drug Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
